Background {#Sec1}
==========

End-stage renal disease (ESRD) has been defined as the start of renal replacement therapy or death relegated to renal diseases, its increasing worldwide prevalence represents a major economic and health burden \[[@CR1], [@CR2]\]. Renal transplantation is currently the therapy of choice for ESRD in children and adolescents \[[@CR3], [@CR4]\]. Approximately 20% of cases of renal disease progress to ESRD, for which the treatment of choice is also a kidney transplant \[[@CR5]\]. Acute rejection in patients with renal transplantation can damage the transplanted renal tissue, even to the point of loss of renal function, which can threaten the life of the patient. At present, some studies show that some gene polymorphisms were associated with the risk of acute kidney allograft rejection \[[@CR6]--[@CR9]\], but some studies indicate that some gene polymorphisms were not associated with the risk of acute rejection susceptibility in recipients with renal transplantation \[[@CR10]--[@CR12]\]. Gene polymorphism can affect the expression level and the protein function, and there are some meta-analyses to assess the relationship between some gene polymorphism and the risk of acute rejection of kidney, but the conclusion is conflicting \[[@CR11], [@CR13]--[@CR16]\]. Early detection and accurate management of acute rejection of kidney are important to the long-term health of each transplant recipient \[[@CR17]\]. It is essential and very important to study the risk factors for the acute rejection in patients with renal transplantation.

Transforming-growth factor β1 (TGF-β1) is a multifunctional pro-fibrotic cytokine and involves in the physiological processes associated with growth, differentiation, and fibrosis \[[@CR18], [@CR19]\]. In contrast, TGF-β1 is a powerful immunoregulatory cytokine that inhibits T-cell activation, and TGF-β1 gene polymorphisms, especially in the position of + 869 T/C or + 915 G/C, encodes the signaling sequence of the TGF-β1 protein, and modify the production of cytokine \[[@CR20], [@CR21]\]. TGF-β1 + 869 T/C gene polymorphism results in the change of codon 10 from leucine (T) to proline (C), and TGF-β1 + 915 G/C gene polymorphism results in the change of codon 25 from arginine (G) to proline (C). In vitro, the presence of leucine or arginine, respectively, has been indicated to lead to a higher production of TGF-β1 \[[@CR22]\]. TGF-β1 production might correlate with reduced incidence of acute rejection, since it down-regulates Th1 responses and Th1 cytokine production \[[@CR21]\]. Single-nucleotide polymorphisms are associated with the risk of some diseases and drug dose requirement in kidney recipients \[[@CR23]--[@CR27]\]. The current evidence indicates that TGF-β1 involves in the pathogenesis of acute rejection in patients with renal transplantation. TGF-β1 + 869 T/C and + 915 G/C gene polymorphisms, which are important variants of TGF-β1, are reported to be associated with the risk of acute rejection.

In previous, Ge et al. \[[@CR28]\] investigated the associations between the TGF-β1 polymorphisms of acute rejection susceptibility. It showed that TGF-β1 + 869 T/C gene polymorphism was not associated with the susceptibility of acute rejection in recipients with renal transplantation. Another meta-analysis \[[@CR29]\] including 9 studies had investigated the combined effects of human + 869 T/C and + 915 G/C polymorphisms in the TGF-β1 gene with risk factors of renal transplantation, and indicated that recipient TGF-β1 high producer haplotypes were not significantly associated with an increased risk for acute rejection susceptibility in recipients with renal transplantation. However, the sample size is relatively small that it may be omit a small effect. Different types of ethnicity may also lead to different findings. We performed a meta-analysis of more studies to determine whether the TGF-β1 + 869 T/C and + 915 G/C gene polymorphisms are associated with the risk of acute rejection in renal transplantation.

Methods {#Sec2}
=======

1. Search strategy {#Sec3}
------------------

Two investigators (HYL and TBZ) independently searched the Cochrane Library and PubMed databases through October 1, 2018 using the terms '(transforming growth factor-beta 1 OR TGF-β1) AND (polymorphism OR genotype OR allele) AND (acute rejection OR early graft rejection OR kidney transplant OR renal transplant OR allograft nephropathy OR rejection graft)'. The references of retrieved reports and association reviews were checked for additional missing data that we failed to identify during the electronic search.

2. Inclusion and exclusion criteria {#Sec4}
-----------------------------------

**Inclusion criteria:** (1) The study provided detailed genotype data regarding TGF-β1 + 869 T/C and + 915 G/C distribution; (2) the study was given a case-control design; (3) the outcome was risk of acute rejection in the recipients with renal transplantation.

Exclusion criteria {#Sec5}
------------------

\(1\) study was unrelated to the association between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and the risk of acute rejection in the recipients with renal transplantation; (2) review articles, case reports and editorials; (3) study had not provided the data of control group; (4) data was incomplete or missing; (5) animal study; (6) data was duplicated.

Two investigators (HYL and TBZ) independently conducted the literature screening process according to inclusion and exclusion criteria, and disagreements were resolved through discussion (WSL and SJL).

3. Data extraction {#Sec6}
------------------

The information was extracted by two investigators (HYL and TBZ) independently from each included study: first author, publication years, country/district of study, ethnicity, and the number of case group and control group for TGF-β1 + 869 T/C and + 915 G/C genotypes. The frequencies of T and G alleles in TGF-β1 + 869 T/C and + 915 G/C were counted for the cases and controls. Disagreements were resolved through discussion (WSL and SJL).

4. Quality assessment of the included studies {#Sec7}
---------------------------------------------

The quality assessment of the included case-control studies recruited into this study was assessed by 2 investigators (TBZ and HYL) using the method of Newcastle-Ottawa Scale (NOS) \[[@CR30], [@CR31]\]. Major aspects to be assessed including selection of study subjects (four scores in total); exposure factors or outcomes (three scores in total); inter-group comparability (two scores in total). A score equal to or higher than 6 was regarded as high-quality studies, otherwise, less than 5 was considered as low-quality studies. Disagreements were resolved through discussion (WSL and SJL).

5. Statistical analysis {#Sec8}
-----------------------

The pooled OR (odds ratio) with 95% confidence interval (95% CI) were evaluated to test the strength of associations between the TGF-β1 + 869 T/C or + 915 G/C gene polymorphisms and the risk of acute rejection in the recipients with renal transplantation. The I^2^ index was used to check heterogeneity assumption. When I^2^ ≥ 50% and *P* \< 0.05, a Der-Simonian and Laird random-effects model was used to analyze data. Otherwise, a Mantel-Haenszel fixed-effects model was used. The Egger regression asymmetry test \[[@CR32]\] and Begg adjusted rank correlation test \[[@CR33]\] were used to calculate publication bias (*P* \< 0.1 was considered significant). The available data from each investigation were extracted and calculated using Cochrane Review Manager Version 5.3 \[[@CR34]\]. Hardy-Weinberg equilibrium (HWE) teat was assess for the genotype distribution of the control group (HWE; *P* \< 0.05 was considered significant). Sensitivity analysis was performed when studies with controls not in HWE. Sensitivity analysis was also conducted according to omit each individual study and switching from fixed effect to random effect.

Results {#Sec9}
=======

Study characteristics {#Sec10}
---------------------

There were 18 studies \[[@CR20], [@CR35]--[@CR51]\] about the relationship between TGF-β1 + 869 T/C gene polymorphism and risk of acute rejection in patients with renal transplant (Fig. [1](#Fig1){ref-type="fig"}). We extracted the interesting data and calculated the T allele frequencies of TGF-β1 + 869 T/C in the case group and control group. One thousand five hundred eight patients with acute rejection and 2784 controls were included. Basical characteristics of included studies were presented in Table [1](#Tab1){ref-type="table"}. We used the method of NOS to assess the quality of individual studies, and found all the included studies for TGF-β1 + 869 T/C gene polymorphism was regarded as high-quality studies (Table [1](#Tab1){ref-type="table"}).Fig. 1Flow diagram of this meta-analysisTable 1Characteristics of studies evaluating the effects of the transforming growth factor-beta 1 (TGF-β1) + 869 T/C gene polymorphism on the risk of acute rejection in renal transplantation patientsFirst author andCountry/DistrictEthnicityARNon-ARHWENOSyearTTTCCCTotalTTTCCCTotal(Y/N)scoresMarshall et al. 2000UKCaucasian4655131143948895Y8Alakulppi et al. 2004FinlandCaucasian31----50115----241--6Ligeiro et al. 2004PortugalCaucasian12127311415635Y7Chow et al. 2005ChinaAsian8----5213----77--8Guo et al. 2005ChinaAsian181563918571590N6Dmitrienko et al. 2005CanadaCaucasian1624105016241050Y7Gendzekhadze et al. 2006VenezuelaMixed12126301014933Y8Hueso et al. 2006SpainCaucasian6531420281563Y6Canossi et al. 2007ItalyCaucasian41562514291861Y7Brabcova et al. 2007Czech RepublicCaucasian3291671903412884246Y7Manchanda et al. 2008IndiaAsian11161819451882Y6Mendoza-Carrera et al. 2008MéxicoMixed----819----732--7Grinyóet al 2008SpainCaucasian18341163666926161Y6Karimi et al. 2012IranAsian58162917243071N7Seyhun et al. 2012TurkeyCaucasian61031916312471Y7Dhaouadi et al. 2013TunisiaAfrican5517880105388151Y7Saigo et al. 2014JapanAsian516324226138121Y7Seyhun et al. 2015TurkeyCaucasian61572816281862Y7*AR* acute rejection, *Non-AR* non- acute rejection, *HWE* Hardy-Weinberg equilibrium, *Y* yes, *N* no, *NOS* Newcastle--Ottawa scale. A total score of NOS for each study can vary from 0 (worst) to 9 (best), low-quality studies: 0 to 4 points; high-quality studies: 5 to 9 points

Eight studies \[[@CR20], [@CR36], [@CR42] [@CR49], [@CR52]--[@CR55]\] about the association of TGF-β1 + 915 G/C gene polymorphism with the susceptibility of acute rejection in patients with renal transplantation were included (Fig. [1](#Fig1){ref-type="fig"}). The interesting data were extracted, and the G allele frequencies of TGF-β1 + 915 G/C for the case group and the control group were counted. Four hundred sixty-two patients with acute rejection and 1099 controls were included in the 8 studies. The characteristics of included investigations were showed in Table [2](#Tab2){ref-type="table"}. The method of NOS was used to assess the quality of individual studies, and the results indicated that all the included studies for TGF-β1 + 915 G/C gene polymorphism was regarded as high-quality studies (Table [2](#Tab2){ref-type="table"}).Table 2Characteristics of the studies evaluating the effects of the transforming growth factor-beta 1 (TGF-β1) +915 G/C gene polymorphism on the risk of acute rejection in renal transplantation patientsFirst author andCountry/DistrictEthnicityARNon-ARHWENOSyearTTTCCCTotalTTTCCCTotal(Y/N)scoresAlakulppi et al. 2004FinlandCaucasian48----50210----241--6Park et al. 2004KoreaAsian13001315100151Y7Dmitrienko et al. 2005CanadaCaucasian408250436150N7Li et al. 2007ChinaAsian4064504915670Y8Seyhun et al. 2012TurkeyCaucasian1711194823071Y7Dhaouadi et al. 2013TunisiaAfrican5517880105388151Y7Chen et al. 2014France etc.Caucasian419050243311275Y7Seyhun et al. 2015TurkeyCaucasian1202821506623190Y7*AR* acute rejection, *Non-AR* non- acute rejection, *HWE* Hardy-Weinberg equilibrium, *Y* yes, *N* no, *NOS* Newcastle--Ottawa scale. A total score of NOS for each study can vary from 0 (worst) to 9 (best), low-quality studies: 0 to 4 points; high-quality studies: 5 to 9 points

Association of TGF-β1 + 869 T/C gene polymorphism with the susceptibility of acute rejection in patients with renal transplantation {#Sec11}
-----------------------------------------------------------------------------------------------------------------------------------

In this meta-analysis, there was no statistic association between TGF-β1 + 869 T/C gene polymorphism and the susceptibility of acute rejection in patients with renal transplantation (CC genotype: OR = 1.04, 95% CI: 0.84--1.30, *P* = 0.70; TT genotype: OR = 1.08, 95% CI: 0.89--1.31, *P* = 0.44; T allele: OR = 1.01, 95% CI: 0.88--1.15, *P* = 0.93; Fig. [2](#Fig2){ref-type="fig"} for CC genotype, Fig. [3](#Fig3){ref-type="fig"} for TT genotype and Fig. [4](#Fig4){ref-type="fig"} for T allele; Table [3](#Tab3){ref-type="table"}).Fig. 2Association between the TGF-β1 + 869 T/C CC genotype and risk of acute rejection in renal transplantation patients. AR: acute rejection; Non-AR: non- acute rejection; M-H: Mantel-Haenszel; CI: confidence intervalFig. 3Association between the TGF-β1 + 869 T/C TT genotype and risk of acute rejection in renal transplantation. AR: acute rejection; Non-AR: non- acute rejection; M-H: Mantel-Haenszel; CI: confidence intervalFig. 4Association between the TGF-β1 + 869 T/C T allele and risk of acute rejection in renal transplantation. AR: acute rejection; Non-AR: non- acute rejection; M-H: Mantel-Haenszel; CI: confidence intervalTable 3Meta-analysis of the association between the TGF-β1 + 869 T/C gene polymorphism with the risk of acute rejection in renal transplantationGenetic contrastsGroups and subgroupsStudiesQ testModel selectedOR (95% CI)*PP* valueT vs COverall150.30Fixed1.01 (0.88, 1.15)0.93Caucasian90.78Fixed0.99 (0.84, 1.16)0.88Asian40.02Random1.03 (0.58, 1.82)0.93African1--Fixed0.84 (0.52, 1.36)0.47TT vs (TC + CC)Overall170.19Fixed1.08 (0.89, 1.31)0.44Caucasian100.45Fixed1.05 (0.83, 1.33)0.67Asian50.03Random1.06 (0.47, 2.41)0.88African1--Fixed0.96 (0.54, 1.73)0.90CC vs (TC + TT)Overall160.57Fixed1.04 (0.84, 1.30)0.70Caucasian90.89Fixed0.99 (0.76, 1.29)0.95Asian40.13Fixed1.01 (0.62, 1.67)0.96African1--Fixed1.99 (0.72, 5.51)0.19

Then we tried a sub-group to control confounding factor, and the results showed no statistic association between TGF-β1 + 869 T/C gene polymorphism and acute rejection in recipients with renal transplantation in Caucasians, Asians, or Africans as well (Table [3](#Tab3){ref-type="table"}).

Relationship between TGF-β1 + 915 G/C gene polymorphism and the susceptibility of acute rejection in patients with renal transplantation {#Sec12}
----------------------------------------------------------------------------------------------------------------------------------------

In our meta-analysis, TGF-β1 + 915 G/C gene polymorphism showed no statistic association with the susceptibility of acute rejection in patient with kidney transplantation (CC genotype: OR = 1.67, 95% CI: 0.84--3.31, *P* = 0.14; GG genotype: OR = 1.24, 95% CI: 0.91--1.69, *P* = 0.17; G allele: OR = 1.04, 95% CI: 0.79--1.37, *P* = 0.80; Fig. [5](#Fig5){ref-type="fig"}; Table [4](#Tab4){ref-type="table"}).Fig. 5Association between the TGF-β1 + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation patients for overall populations. AR: acute rejection; Non-AR: non- acute rejection; M-H: Mantel-Haenszel; CI: confidence intervalTable 4Meta-analysis of the association between the TGF-β1 + 915G/C gene polymorphism with acute rejection risk in renal transplantationGenetic contrastsGroups and subgroupsNumber of studiesQ testModel selectedOR (95% CI)*PP* valueG vs COverall70.26Fixed1.04 (0.79, 1.37)0.80Caucasian40.19Fixed1.06 (0.72, 1.56)0.76Asian2--Fixed1.47 (0.73, 2.97)0.29African1--Fixed0.84 (0.52, 1.36)0.47GG vs (GC + CC)Overall80.11Fixed1.24 (0.91, 1.69)0.17Caucasian50.06Random1.29 (0.65, 2.55)0.47Asian2--Fixed1.71 (0.72, 4.06)0.22African1--Fixed0.96 (0.54, 1.73)0.90CC vs (GC + GG)Overall70.80Fixed1.67 (0.84, 3.31)0.14Caucasian40.74Fixed2.31 (0.60, 8.89)0.22Asian2--Fixed0.93 (0.25, 3.47)0.91African1--Fixed1.99 (0.72, 5.51)0.19

In the sub-group analysis by ethnicity subsequently, no statistic association was showed between TGF-β1 + 915 G/C gene polymorphism and the susceptibility of acute rejection in patients with kidney transplantation in Asians, Caucasians, and Africans either (Table [4](#Tab4){ref-type="table"}).

Sensitivity analysis {#Sec13}
--------------------

These studies in HWE were included for sensitivity analysis, and the results indicated that TGF-β1 + 869 T/C gene polymorphism was not associated with the susceptibility of acute rejection in patients with renal transplantation (CC genotype: OR = 0.98, 95% CI: 0.77--1.25, *P* = 0.88; TT genotype: OR = 0.96, 95% CI: 0.77--1.20, *P* = 0.70; T allele: OR = 0.99, 95% CI: 0.86--1.14, P = 0.88). TGF-β1 + 915 G/C gene polymorphism was also not associated with the susceptibility of acute rejection in patient with kidney transplantation (CC genotype: OR = 1.64, 95% CI: 0.80--3.34, *P* = 0.17; GG genotype: OR = 1.22, 95% CI: 0.87--1.70, *P* = 0.25; G allele: OR = 1.09, 95% CI: 0.81--1.45, *P* = 0.58).

We also conducted the sensitivity analysis by omitting each individual study, and found the results were similar to those non-sensitivity analyses. Sensitivity analysis by switching from fixed effect to random effect was also performed and the results indicated that the results were also similar to those non-sensitivity analyses.

Evaluation of publication bias {#Sec14}
------------------------------

There was no significant publication bias for TGF-β1 + T869C gene polymorphism in overall population (Begg *P* = 0.202, funnel plot was presented in Fig. [6](#Fig6){ref-type="fig"}; Egger *P* = 0.420).Fig. 6Publication bias was evaluated for the overall populations (**a**: + 869 T/C; **b**: + 915 G/C). OR, odds ratio; SE, standard error

No statistic significant publication bias was detected for TGF-β1 + 915 G/C gene polymorphism in the overall populations (Begg *P* = 0.711, funnel plot was presented in Fig. [6](#Fig6){ref-type="fig"}; Egger *P* = 0.572).

Discussion {#Sec15}
==========

Some reports \[[@CR56], [@CR57]\] showed gene polymorphisms were the susceptibility factor of acute rejection in patients with renal transplantation. However, our meta-analysis results indicated that there were no association between TGF-β1 + 869 T/C gene polymorphism, TGF-β1 + 915 G/C gene polymorphism and the susceptibility of acute rejection in patients with kidney transplantation in the overall population; this relationship was somewhat robust. No publication bias was detected for this analysis, and the results might be robust. Sub-group analysis according to ethnicity was conducted to assess the conclusion.

No association was also found between the TGF-β1 + 869 T/C gene polymorphism, the TGF-β1 + 915 G/C gene polymorphism, and the susceptibility of acute rejection in patients with kidney transplantation in Caucasians, Asians, and Africans in subsequent sub-group analysis. Caucasians, Asians, and Africans were included in those studies but all with small sample sizes. The results also should be regarded cautiously, and more association studies were still needed to assess this relationship further.

The sensitivity analyses were conducted according to HWE and by omitting each individual study and switching from fixed effect to random effect, and the results were similar with those from non-sensitivity analyses. All included studies for this meta-analysis were judged as high quality, so we did not conduct the sensitivity analysis according to NOS score. The results might be robust to some extent, but more association studies were also needed to assess this relationship further.

In previous work, Ge's et al. meta-analysis of 12 investigations indicated no association in TGF-β1 + 869 T/C gene polymorphism and the susceptibility of acute rejection in patients with renal transplantation in the overall population of China \[[@CR28]\]. In our meta-analysis, 18 investigations were included, rendering the sample size much larger, so our results were more robust in some way. Besides, there was no other meta-analysis assessed this relationship, and our results indicated no association between the TGF-β1 + 915 G/C gene polymorphism and the susceptibility of acute rejection in patients with kidney transplantation in Asians, Caucasians, Africans, and the overall population. Nevertheless, these discoveries were considered to be retained, for the reason that many other factors, like objective probability of small sample in the recruited reports, unbalanced cases number between acute rejection group and non-acute rejection group, language bias, limited statistical power, heterogeneity of the enrolled patients, and clinical diversity of different study design and diverse intervention (such as immunosuppressive therapy), are capable of affecting the results. Furthermore, haplotypes analysis might give new information.

Conclusion {#Sec16}
==========

In conclusion, our meta-analysis supported no association between TGF-β1 + 869 T/C gene polymorphism and the TGF-β1 + 915 G/C gene polymorphism with the susceptibility of acute rejection in patients with renal transplantation in Asians, Caucasians, Africans, or the overall human population. However, more association investigations are needed to absolutely justify this verdict.
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